Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2022	Mar. 31, 2022
ASSETS
Cash and cash equivalents	$ 6,311	$ 7,670
Restricted cash and cash equivalents	1,855	2,065
Investments in marketable securities	4,388	4,953
Finance receivables, net of allowance for credit losses of $1,366 and $1,246	86,890	82,432
Investments in operating leases, net	32,114	35,455
Other assets	2,794	2,466
Total assets	134,352	135,041
LIABILITIES AND SHAREHOLDER'S EQUITY
Debt	108,873	109,152
Deferred income taxes	1,277	1,564
Other liabilities	5,861	6,224
Total liabilities	116,011	116,940
Commitments and contingencies (Refer to Note 9)
Shareholder's equity:
Capital stock, no par value (100,000 shares authorized; 91,500 issued and outstanding) at September 30, 2022 and March 31, 2022	915	915
Additional paid-in capital	2	2
Accumulated other comprehensive loss	(70)	(21)
Retained earnings	17,494	17,205
Total shareholder's equity	18,341	18,101
Total liabilities and shareholder's equity	$ 134,352	$ 135,041